Pancreatic Early Surgery Boosts Success Rate

Pancreatic Early Surgery Boosts Success Rate

A study conducted by the Birmingham team reveals that surgery soon after early diagnosis of pancreatic cancer has greater success rate, according to BBC News on August 1, 2017.

A trial involved 32 patients diagnosed with pancreatic cancer who underwent a surgery within two weeks of diagnosis. The time period of two months is usually the average time frame for patients to undergo surgery after diagnosis. The early surgery resulted in successful removal of tumors in 31 out of 32 patients. Doctors have yet to examine whether or not, early operation extends life.

According to BBC, 9,600 people are diagnosed with pancreatic cancer in UK, every year and only 7 percent of this population lives beyond five years.

Currently, only 8% of patients diagnosed with pancreatic cancer are able to undergo surgery to successfully eradicate the tumor, while majority are diagnosed at a much advanced stage where surgery is not possible. Even if they are suitable for surgery, the success rate depends solely on the immediate action post diagnosis.

The team of surgeons at University Hospitals Birmingham NHS Foundation Trust worked with a number of hospitals to help speed the process of recommendations for patients and also reorganized the process of surgery.

These surgeons also stopped a treatment believed to reduce risk, generally given to patients with jaundice before surgery. Speeding up the time for surgery after early diagnosis of patients, saw a 97 percent success rate when trialed on 32 patients.

The study concludes that most chronic diseases have the potential of being cured and tumors could be eliminated from the patient’s body, if doctors speed up the treatment to surgery soon after early diagnosis of the disease. This practice could save NHS £3,200 per patient and could help hundreds of patients around the UK.

You may be interested

Hepatitis Vaccine Market To Propel Growth Based on Rising Demand For Growing Consumer Preferences In Pharma | CMI Research
Business
Business

Hepatitis Vaccine Market To Propel Growth Based on Rising Demand For Growing Consumer Preferences In Pharma | CMI Research

Albert R - October 19, 2018

The Hepatitis Vaccine Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently released Hepatitis Vaccine…

Increasing Awareness Of Home-Based Treatments Is A Prominent Factor To Fuel The Remote Patient Monitoring Devices Market
Healthcare
Healthcare

Increasing Awareness Of Home-Based Treatments Is A Prominent Factor To Fuel The Remote Patient Monitoring Devices Market

Mohit Joshi - October 19, 2018

The Remote Patient Monitoring Devices Market is expected to have a highly positive growth outlook from 2018-2025 according to a recently released Remote Patient Monitoring Devices Market research…

Tuberculosis Vaccine Market To Propel Growth Based on Rising Demand For Growing Consumer Preferences In Pharma | CMI Research
Business
Business

Tuberculosis Vaccine Market To Propel Growth Based on Rising Demand For Growing Consumer Preferences In Pharma | CMI Research

Albert R - October 19, 2018

The Tuberculosis Vaccine Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently released Tuberculosis Vaccine…

Most from this category